The nonprofit Infectious Disease Research Institute has commenced the world's first clinical trial of a vaccine against Leishmaniasis. The vaccine,...
Madrigal Pharmaceuticals, Inc. announced that the FDA has granted accelerated approval for Rezdiffra (resmetirom) in conjunction with diet and exercise for the treatment of adults with noncirrhotic NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) .
Qiagen announced the immediate launch of its Therascreen PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) after it received U.S. regulatory...
Kitov Pharmaceuticals has announced that the Phase III, double-blind, placebo-controlled clinical trial for its leading drug candidate, KIT 302 (celecoxib...
BGI Genomics announced that its subsidiary BGI Americas Corporation has received authorization under Interim Order from Health Canada to supply its Real-Time Fluorescent RT-PCR Kit for Detecting SARS-CoV-2 in the Canadian market.
Delcath Systems, Inc.announced that the FDA has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for...
The FDA has granted 510(k) clearance to InBios� DENV Detect NS1 Elisa Kit, used for detection of the dengue virus...
Virax Biolabs Group Limited an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral diseases, announced that it has entered into an agreement for the distribution of an Avian Influenza A Virus ("AIV") real-time PCR test kit to markets accepting the CE mark, namely the European Union.
Innovus Pharmaceuticals, Inc. an emerging commercial-stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products...
The FDA has given marketing approval for the Therascreen KRAS RGQ PCR Kit, from Qiagen, to provide guidance on the...